ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,086Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 51

$1.44M Total Retail Price of All Prescriptions

Rank: 5 out of 51

380 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

38% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

3% of this provider’s 25,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

74 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
FUROSEMIDE 1,276 1,144 1 2
HYDROCODONE-ACETAMINOPHEN 1,109 979 S3 2 1
POLYETHYLENE GLYCOL 3350 1,086 926 3 45
OMEPRAZOLE 862 817 4 3
LEVOTHYROXINE SODIUM 755 703 5 6
LANTUS 701 625 6 31
POTASSIUM CHLORIDE 660 585 7 8
SIMVASTATIN 598 541 8 4
MIRTAZAPINE 578 570 9 21
LISINOPRIL 543 455 10 7
RISPERIDONE 542 516 11 27
WARFARIN SODIUM 457 419 12 11
ESCITALOPRAM OXALATE 454 412 13 39
AMLODIPINE BESYLATE 418 395 14 5
HYDROCHLOROTHIAZIDE 381 333 15 15
NAMENDA 368 359 16 16
DONEPEZIL HCL 354 353 17 17
ALBUTEROL SULFATE 352 298 18 79
FENTANYL 341 322 S2 19 65
METOPROLOL TARTRATE 334 324 20 14
IPRATROPIUM BROMIDE 328 283 21 97
GABAPENTIN 326 273 22 12
CITALOPRAM HBR 298 288 23 18
CARVEDILOL 278 271 24 13
DIVALPROEX SODIUM 256 244 25 44
NOVOLIN 70-30 238 191 26 89
DIGOXIN 234 234 27 42
RANITIDINE HCL 228 193 28 28
EXELON 225 224 29 50
ATENOLOL 222 218 30 33
HUMULIN 70-30 190 185 31 104
FLUOXETINE HCL 188 163 32 60
SPIRONOLACTONE 188 172 32 68
PROMETHAZINE HCL 178 172 R 34 56
QUETIAPINE FUMARATE 178 162 34 38
METFORMIN HCL 177 154 36 9
TRAMADOL HCL 177 163 36 10
CLOPIDOGREL 172 158 38 41
GLYBURIDE 161 155 R 39 119
NITROFURANTOIN 155 136 40 133
NYSTATIN 153 150 41 107
TRAZODONE HCL 151 119 42 23
LEVETIRACETAM 149 110 43 61
NEXIUM 149 126 43 24
TAMSULOSIN HCL 147 135 45 36
ALLOPURINOL 147 147 45 43
KLOR-CON M10 145 139 47 159
SERTRALINE HCL 140 123 48 32
PANTOPRAZOLE SODIUM 140 123 48 34
PLAVIX 135 118 50 58
HUMULIN R 135 127 50 112
CARBIDOPA-LEVODOPA 131 121 52 74
LIDOCAINE HCL 130 111 53 148
CEFTRIAXONE 129 120 54 100
PAROXETINE HCL 120 88 55 69
MEGESTROL ACETATE 119 119 R 56 88
PRADAXA 117 111 57 193
OLANZAPINE 117 117 57 92
MELOXICAM 112 112 59 20
DILTIAZEM 24HR CD 107 105 60 106
CLONIDINE HCL 105 86 61 26
IBUPROFEN 99 98 62 93
NOVOLIN R 99 83 62 78
OXYBUTYNIN CHLORIDE 99 89 62 142
OXYBUTYNIN CHLORIDE ER 97 89 65 94
SUCRALFATE 95 94 66 82
CEPHALEXIN 91 81 67 67
ISOSORBIDE MONONITRATE ER 88 80 68 57
DIVALPROEX SODIUM ER 87 72 69 114
PRAVASTATIN SODIUM 82 66 70 19
LEXAPRO 82 77 70 117
HYDROXYZINE HCL 81 81 R 72 99
LACTULOSE 81 78 72 121
FAMOTIDINE 80 63 74 55
TRIAMCINOLONE ACETONIDE 79 69 75 140
AMIODARONE HCL 79 79 75 124
DICYCLOMINE HCL 77 71 77 177
BUSPIRONE HCL 76 76 78 77
CELEBREX 75 75 79 129
AZITHROMYCIN 74 66 80 47
MECLIZINE HCL 74 69 80 103
HALOPERIDOL 73 53 82 105
METHIMAZOLE 73 73 82 270
METOCLOPRAMIDE HCL 71 59 84 64
ATORVASTATIN CALCIUM 70 70 85 30
AMITRIPTYLINE HCL 70 57 R 85 49
THEOPHYLLINE ANHYDROUS 70 50 85 156
BENZTROPINE MESYLATE 69 47 R 88 91
CLEMASTINE FUMARATE 69 63 R 88 239
PHENYTOIN SODIUM EXTENDED 69 46 88 84
TERBUTALINE SULFATE 68 48 91 279
LEVEMIR 68 53 91 111
OXCARBAZEPINE 67 67 93 187
LYRICA 67 50 93 54
ABILIFY 67 49 93 101
CYMBALTA 65 58 96 37
SEROQUEL 64 53 97 86
IPRATROPIUM-ALBUTEROL 64 64 97 147
RIVASTIGMINE 64 57 97 192
NOVOLOG 62 42 100 151
CIPROFLOXACIN HCL 62 55 100 48
RESTASIS 62 58 100 203
CARAFATE 61 46 103 185
CYCLOBENZAPRINE HCL 58 32 R 104 53
PREDNISONE 58 44 104 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 50 106 62
ENALAPRIL MALEATE 57 56 106 81
RAMIPRIL 57 57 106 73
PROPRANOLOL HCL 55 45 109 154
LOSARTAN POTASSIUM 55 55 109 29
ZOLPIDEM TARTRATE 53 38 111 22
DILANTIN 53 36 111 205
CRESTOR 52 37 113 46
HYDRALAZINE HCL 52 40 113 52
BUPROPION HCL 51 51 115 310
DILTIAZEM HCL 51 51 115 168
DIOVAN 51 38 115 70
VESICARE 50 45 118 181
PRIMIDONE 50 37 118 139
GLIMEPIRIDE 50 38 118 71
MORPHINE SULFATE 50 27 S2 118 232
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.